Search Icon
Home
Resources
Reports

Reports

  • Reports

Report: 2023 U.S. Generic and Biosimilar Medicines Savings Report
  • Reports

AAM White Paper on Shortages
  • Reports

AAM Voices of Access
  • Reports

Report: 2022 U.S. Generic and Biosimilar Medicines Savings Report
  • Reports

AAM Voices of Access 2022
  • Reports

AAM Code of Business Ethics
  • Reports

Report: 2021 U.S. Generic and Biosimilar Medicines Savings Report
  • Reports

White Paper: Nitrosamines — An Industry Position Paper Based on Risk
  • Reports

2017 Generic Drug Access and Savings Report
  • Reports

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors
  • Reports

Roadmaps for Ensuring Patient Access to Generic and Biosimilar Medicines: Securing Sustainable Markets
  • Reports

White Paper: Potential Savings from Accelerating U.S. Approval of Complex Generics
Load More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe
© 2024 Association for Accessible Medicines (AAM), All Rights Reserved Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram